Pricing Log in Create free account
Friday 6 November 2026 Export STVN’s income statement to Excel — free account

Stevanato Group S.p.A.

STVN Healthcare Medical Instruments & Supplies

Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.

Revenue
+5.91%
EPS
+17.5%
Free cash flow
+4,089.9%
Total debt
+2.85%

Quarter to September 2026, against a year earlier

13.12 0.32 −2.38%
Market cap
$3.6B
P/E
22.4×
Fwd P/E
30.2×
Dividend yield
0.48%
F-score
5/9
Altman Z
4.48
Beneish M
−2.79
Dividend safety
63/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Stevanato Group S.p.A. (STVN) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Stevanato Group S.p.A. (STVN) trades at a EV/EBITDA of 11.3×. Over the past ten years it has ranged from 11.3× (November 2026) to 33.7× (August 2023) — the current reading is the lowest in ten years. That is below the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 18.0× (24.74%)
FY2024 24.0× (2.02%)
FY2023 24.5× 44.63%
FY2022 16.9× (19.71%)
FY2021 21.1× (5.73%)
FY2020 22.3× 0.00%
FY2019 22.3× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 17.5× 11.49%
Jun 2026 15.7× 29.01%
Mar 2026 12.1× (32.71%)
Dec 2025 18.0× (24.18%)
22 more quarters

Against its own ten years

Low 11.3× High 33.7×
Ten-year median 22.0×
Current reading's percentile 0

EV/EBITDA against peers

Company EV/EBITDA
PLSE Pulse Biosciences, Inc compare n/m
MMED MiniMed Group, Inc. compare n/m
NVST Envista Holdings Corporation compare 10.3×
STVN Stevanato Group S.p.A. 11.3×
MMSI Merit Medical Systems, Inc. compare 15.5×
ICUI ICU Medical, Inc. compare 16.0×
TFX Teleflex Incorporated compare 35.7×
WRBY Warby Parker Inc. compare 50.2×
ATRC AtriCure, Inc. compare 83.7×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on STVN